BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10510812)

  • 1. [Guidelines for radioiodine therapy (RIT) in differentiated thyroid cancer].
    Dietlein M; Dressler J; Farahati J; Leisner B; Moser E; Reiners C; Schicha H; Schober O
    Nuklearmedizin; 1999; 38(6A):221-2. PubMed ID: 10510812
    [No Abstract]   [Full Text] [Related]  

  • 2. [Guidelines for radioiodine therapy (RIT) in benign thyroid diseases].
    Dietlein M; Dressler J; Joseph K; Leisner B; Moser E; Reiners C; Schicha H; Schneider P; Schober O
    Nuklearmedizin; 1999; 38(6A):219-20. PubMed ID: 10510811
    [No Abstract]   [Full Text] [Related]  

  • 3. Guidelines on radioiodine therapy for differentiated thyroid carcinoma: impact on clinical practice.
    Biermann M; Pixberg MK; Dörr U; Dietlein M; Schlemmer H; Grimm J; Zajic T; Nestle U; Ladner S; Sepehr-Rezai S; Rosenbaum S; Puskás C; Fostitsch P; Heinecke A; Schuck A; Willich N; Schmid KW; Dralle H; Schober O;
    Nuklearmedizin; 2005; 44(6):229-34, 236-7. PubMed ID: 16400382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Procedures for the radioiodine test].
    Dietlein M; Dressler J; Eschner W; Leisner B; Reiners C; Schicha H
    Nuklearmedizin; 1999; 38(6A):211-2. PubMed ID: 10510808
    [No Abstract]   [Full Text] [Related]  

  • 5. [Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 3)].
    Dietlein M; Dressler J; Eschner W; Grünwald F; Lassmann M; Leisner B; Luster M; Moser E; Reiners C; Schicha H; Schober O; ;
    Nuklearmedizin; 2007; 46(5):213-9. PubMed ID: 17938757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Procedure guidelines for radioiodine therapy of differentiated thyroid cancer (version 2)].
    Dietlein M; Dressler J; Farahati J; Grünwald F; Leisner B; Moser E; Reiners C; Schicha H; Schober O;
    Nuklearmedizin; 2004 Aug; 43(4):115-20. PubMed ID: 15316577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presentation and practical management to optimize radioiodine treatment of well differentiated thyroid cancer: ablation of thyroid remnants with radioiodine.
    Janisch A; Altenbrunn HJ; Markwardt J
    Radiobiol Radiother (Berl); 1987; 28(5):707-10. PubMed ID: 3441634
    [No Abstract]   [Full Text] [Related]  

  • 8. [Procedure guidelines for radioiodine therapy of differentiated thyroid cancer. Version 4].
    Dietlein M; Eschner W; Grünwald F; Lassmann M; Verburg FA; Luster M
    Nuklearmedizin; 2016 Jun; 55(3):77-89. PubMed ID: 27350004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioiodine therapy in differentiated thyroid cancer: a nuclear medicine perspective.
    Clarke SE
    Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):430-7. PubMed ID: 20537878
    [No Abstract]   [Full Text] [Related]  

  • 10. [The initial treatment of patients with differentiated thyroid carcinoma; consensus and controversies].
    Smit JW
    Ned Tijdschr Geneeskd; 2002 Mar; 146(10):454-7. PubMed ID: 11913107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved planning of radioiodine therapy for thyroid cancer.
    Medvedec M
    J Nucl Med; 2002 May; 43(5):714; author reply 714. PubMed ID: 11994536
    [No Abstract]   [Full Text] [Related]  

  • 12. [Surgery and follow-up 131I therapy in patients with differentiated thyroid carcinoma in the south-east of the Netherlands, 1983-1996, compliance with the 1987 consensus guidelines: additional data].
    Kuijpens JL; Verheij CD; Haak HR; Ribot JG; Hoekstra OS; Coebergh JW
    Ned Tijdschr Geneeskd; 2004 Sep; 148(37):1835-6. PubMed ID: 15495514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Radioiodine therapy of differentiated thyroid cancer. Recommendations of the Therapy Study Group of the German Society of Nuclear Medicine].
    Georgi P; Emrich D; Heidenreich P; Moser E; Reiners C; Schicha H
    Nuklearmedizin; 1992 Aug; 31(4):151-3. PubMed ID: 1518724
    [No Abstract]   [Full Text] [Related]  

  • 14. Radioiodine therapy of thyroid autonomy.
    Reiners C; Schneider P
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S471-8. PubMed ID: 12192548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of relapse following radiotherapy for differentiated thyroid cancer: implication for target volume delineation.
    Azrif M; Slevin NJ; Sykes AJ; Swindell R; Yap BK
    Radiother Oncol; 2008 Oct; 89(1):105-13. PubMed ID: 18579244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial radioiodine administration: when to use it and how to select the dose.
    Esposito G
    Endocrinol Metab Clin North Am; 2014 Jun; 43(2):385-400. PubMed ID: 24891168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancer.
    Lassmann M; Luster M; Hänscheid H; Reiners C
    J Nucl Med; 2005 May; 46(5):899. PubMed ID: 15872368
    [No Abstract]   [Full Text] [Related]  

  • 18. Radioiodine in the treatment of thyroid cancer.
    Van Nostrand D; Wartofsky L
    Endocrinol Metab Clin North Am; 2007 Sep; 36(3):807-22, vii-viii. PubMed ID: 17673129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid cancer guidelines--what's new?
    Gerrard G; Gill V
    Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):264-6. PubMed ID: 18343311
    [No Abstract]   [Full Text] [Related]  

  • 20. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
    Jarzab B; Handkiewicz-Junak D; Wloch J
    Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.